Back to Journals » Drug Design, Development and Therapy » Volume 13

Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways

Total article views   HTML views PDF downloads Totals
7,947 Dovepress* 7,195+ 1,434 8,629
PubMed Central* 752 238 990
Totals 7,947 1,672 9,619
*Since 11 January 2019

View citations on PubMed Central and Google Scholar